Banker Haris Santana argues that apps have made banking quicker, but customer trust is still won by people who explain, help and act when something goes wrong.
Mobile apps have taken much of the waiting out of banking.
FI Works founder Keith Henkel says community banks and credit unions have the data, but lack a way to turn a warning sign into a call to the right person.
FI Works, which builds a relationship intelligence and engagement platform for community banks and credit unions, has launched Signals, a feature that uses machine learning to spot households likely to add a product, take up digital services or leave the
Netcall's Pol Brouckaert argues that as AI makes fake documents easier to produce, checks on whether evidence can be trusted must sit inside workflows.
Businesses have spent years automating the processing of claims, applications and supporting documents.
LemFi co-founder and CEO Ridwan Olalere argues that fintech must let migrants carry their credit history and financial identity with them across borders.
More than 300 million people now live outside their country of birth, and for many of them a credit history does not survive the move. The founder of one cross-border finance platform argues that this is the gap fintech has so far left open.
Hassan Allam's development arm commits $1bn to a 303-acre Cairo mixed-use project, signalling accelerating Gulf-linked capital flows into MENA real estate.
Hassan Allam's development arm commits $1bn to a 303-acre Cairo mixed-use project, signalling accelerating Gulf-linked capital flows into MENA real estate.
Nasdaq embeds a governed agentic AI environment into its Calypso platform, targeting the manual-process bottlenecks that block institutional AI adoption.
Nasdaq embeds a governed agentic AI environment into its Calypso platform, targeting the manual-process bottlenecks that block institutional AI adoption.
Nasdaq-listed Solmate says it plans to resell UAE-sourced GPU capacity for AI training and inference, with payment options including Solana stablecoins.
The EMA's advisory committee recommended secukinumab for patients aged 12 and over with moderate to severe hidradenitis suppurativa, with an EC decision expected within